Search for Abstracts Find by Title, Author or Description Year Abstracts - 2025 - 2024 - 2023 - 2022 - 2021 - 2020 - 2019 - 2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 Tags AB Applied Basic Science Basic Science BT Clinical Clinical-Chemotherapy-SSA-Biologics Clinical-NuclearMedicine-InterventionalRadiology-Imaging Clinical-PRRT-Nuclear Clinical-Surgical-Applied_Pathology O OT Other P Population Science Poster T Trials In Progress Search Reset Order by Title Alphabetical Title Reverse Alphabetical Most Recent First Oldest First Most popular first Last modified first [T8] Khuong Le - Trial in Progress- Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms (PanNENs) Published in 2024 Listed under T Download [T7] Idrees - Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors Published in 2024 Listed under T Download [T6] Capdevila - DAREON™-7: Phase 1 trial of BI 764532 (a delta-like ligand 3 [DLL3]-targeting T-cell engager) plus chemotherapy for DLL3+ neuroendocrine carcinomas Published in 2024 Listed under T Download [T5] Rao - Can NK1 antagonists and COX-2 inhibitors improve same-day discharge rates following chemoembolization? Published in 2024 Listed under T Download [T5] Poster - Rao - Can NK1 antagonists and COX - 2 inhibitors improve same - day discharge rates following chemoembolization? Published in 2024 Listed under Poster, T Download [T4] Poster - D'Souza - Lipiodol Deposition in Neuroendocrine Tumor Liver Metastases during TACE using Pressure-Enabled versus Endhole Catheters: Pilot Data from a Randomized, Internally-Controlled Trial Published in 2024 Listed under Poster, T Download [T4] D'Souza - Lipiodol Deposition in NET Liver Metastases during TACE using Pressure-Enabled versus Endhole Catheters: Pilot Data from a Randomized, Internally-Controlled Trial Published in 2024 Listed under T Download [T3] Dolkar - Phase 2 Dose Optimization Trial of Everolimus post Bland Hepatic Artery Embolization (Evero-Embo) in patients with Neuroendocrine Tumors Published in 2024 Listed under T Download [T2] Luria - KinLET: Phase I Trial for Dose Determination and Pharmacokinetics Evaluation of [177Lu]Lu-edotreotide Radiopharmaceutical Therapy in Pediatric Participants with SSTR+ Tumors Published in 2024 Listed under T Download [T1] Paulson - Phase 2 study of nab-sirolimus in patients with well- differentiated and advanced/metastatic neuroendocrine tumors of the gastrointestinal tract, lung, or pancreas Published in 2024 Listed under T Download [P9] Fansolato - Shared Care Model (SCM) in the Management of Neuroendocrine Neoplasms (NENs)- Patient Perspective Published in 2024 Listed under P Download [P8] Xu - Risk Factors Associated with Gastroenteropancreatic and Lung Neuroendocrine Tumors: A Nested Case-Control Study from The All of Us Research Program Published in 2024 Listed under P Download [P7] Vasquez - Metastatic Neuroendocrine Tumors to the Breast: A Systematic Review Published in 2024 Listed under P Download [P6] Vasquez - Epidemiological description of a patient’s cohort with diagnosis of neuroendocrine tumors in a Colombian health care institution (CTIC) Published in 2024 Listed under P Download [P5] Al-Toubah - The exceptionally rare phenomenon of well-differentiated colon neuroendocrine tumors Published in 2024 Listed under P Download [P4] Poster - Dureja - Think NENs Global Educational Program on Neuroendocrine Neoplasms Diagnostics and Management for Primary Care Physicians Published in 2024 Listed under P, Poster Download [P4] Dureja - Think NENs Global Education Program on Neuroendocrine Neoplasms Diagnostics and Management for Primary Care Physicians Published in 2024 Listed under P Download [P3] Poster - Dalton - Sexual dimorphism in Small Intestinal NETS: Any association with development of mesenteric metastases? Published in 2024 Listed under Poster Download [P3] Hassan - Sexual dimorphism in Small Intestinal NETS: Any association with development of mesenteric metastases? Published in 2024 Listed under P Download [P2] Poster - Gangi - Novel pathogenic germline variants (PGV) identified in pancreatic neuroendocrine neoplasm (PNEN) patients during genetic testing Published in 2024 Listed under P, Poster Download [P2] Gangi - Novel pathogenic germline variants (PGV) identified in pancreatic neuroendocrine neoplasm (PNEN) patients during genetic testing Published in 2024 Listed under P Download [P1] Poster - Antwi - Rare germline variants in MEN1, TSC1, ATM, and MSH2 are associated with higher risk for pancreatic neuroendocrine tumors Published in 2024 Listed under P, Poster Download [P1] Antwi - Rare germline variants in MEN1, TSC1, ATM, and MSH2 are associated with higher risk of pancreatic neuroendocrine tumors Published in 2024 Listed under P Download [P15] Tobias - Surgery enhances the effectiveness of Peptide Receptor Radionuclide Therapy in metastatic Gastroenteropancreatic Neuroendocrine Tumors Published in 2024 Listed under P Download [P14] Grewal - Comparative Analysis of Characteristics and Outcomes of Patients with Early-Onset versus Average-Onset Small Bowel Neuroendocrine Tumors Published in 2024 Listed under P Download [P13] Poster - Fung - Role of genetic alterations and tumour functionality in predicting peptide receptor radionuclide therapy effectiveness and survival in pancreatic neuroendocrine neoplasm Published in 2024 Listed under P, Poster Download [P13] Fung - Role of genetic alterations and tumor functionality in predicting peptide receptor radionuclide therapy effectiveness and survival in pancreatic neuroendocrine neoplasm Published in 2024 Listed under P Download [P12] Poster - Mailman - US NETs Clinical Trial Searches as Compared to SEER Prevalence Data from 2011-2021 Indicates Potential Areas of Unmet Needs Published in 2024 Listed under P, Poster Download [P12] Mailman - US NETs Clinical Trial Searches as Compared to SEER Prevalence Data from 2011-2021 Indicates Potential Areas of Unmet Needs Published in 2024 Listed under P Download [P11] Tan - Re-examining NCTN Clinical Trials for Sex Differences in Outcomes and Toxicities in Patients with Neuroendocrine Neoplasms Published in 2024 Listed under P Download [P11] Poster - Tan - Re-examining NCTN Clinical Trials for Sex Differences in Outcomes and Toxicities in Patients with Neuroendocrine Neoplasms Published in 2024 Listed under P, Poster Download [P10] Paciorek - Disparities in the rising incidence of early-onset neuroendocrine neoplasms Published in 2024 Listed under P Download [O9] Kollu - Improving PET Scan Report Clarity Using Radiotracer Information: A Physician Survey Published in 2024 Listed under OT Download [O8] Sahvan - From Neuroendocrine Neoplasms to Sarcomas: How Genetic Testing Reveals Diagnostic Pitfalls Published in 2024 Listed under OT Download [O7] Fields - Elevated Cancer Testis Antigen Expression Corresponds to Immune Activation and Improved Survival in Small Bowel Neuroendocrine Tumors Published in 2024 Listed under OT Download [O6] Al-Toubah - Empowering Participation: Trends in APP/AHP Authorship and the Impact of Travel Grants in Neuroendocrine Tumor Research Published in 2024 Listed under OT Download [O5] Poster - Gujarathi - Peptide Receptor Radionuclide Therapy versus Capecitabine/Temozolomide for the treatment of Metastatic Pancreatic Neuroendocrine Tumors Published in 2024 Listed under O, Poster Download [O5] Gujarathi - Peptide Receptor Radionuclide Therapy versus Capecitabine/ Temozolomide for the treatment of Metastatic Pancreatic Neuroendocrine Tumors Published in 2024 Listed under OT Download [O4] Poster - Gujarathi - MEN1 / DAXX alterations are associated with improved overall survival and treatment response in patients with pancreatic neuroendocrine tumors Published in 2024 Listed under O, Poster Download [O4] Gujarathi - MEN1/DAXX alterations are associated with improved overall survival and treatment response in patients with pancreatic neuroendocrine tumors Published in 2024 Listed under OT Download [O3] Poster - Baskar - Racial Disparities in End - Of - Life Care Among Patients with Neuroendocrine Tumors Published in 2024 Listed under Other, Poster Download [O3] Baskar - Racial Disparities in End-of-Life Care Among Patients with Neuroendocrine Tumors Published in 2024 Listed under OT Download [O2] Estrada - Characterization of early-onset gastroenteropancreatic neuroendocrine neoplasms at UCSF Published in 2024 Listed under OT Download [O1] Poster - Hall - Hereditary and Clinical Insights into Paraganglioma and Pheochromocytoma Published in 2024 Listed under Other, Poster Download [O1] Hall - Hereditary Predisposition and Clinical Presentation of Patients with Pheochromocytomas and Paragangliomas: Insights from a Large Clinical Cohort Published in 2024 Listed under OT Download [O15] Grewal - Characterization of the Genomic and Immune Landscapes of 88 Cases of Pheochromocytomas and Paragangliomas: Implications for Development of Targeted Therapeutics Published in 2024 Listed under OT Download [O14] Grewal - Racial Inequities in Neuroendocrine Tumor Clinical Trial Enrollment in the United States Published in 2024 Listed under OT Download [O13] - Singh - Prevalence of CHIP Mutations in patients with Neuroendocrine Tumors and Role in Predicting Hematologic Toxicity to PRRT and Chemotherapy Published in 2024 Listed under P Download [O12] Korleski - The diagnostic accuracy of vasoactive intestinal peptide (VIP) for VIPoma Published in 2024 Listed under OT Download [O11] Poster - Laffan - Health - related quality of life issues in patients with non - metastatic neuroendocrine neoplasms persist after treatment Published in 2024 Listed under O, Poster Download [O11] Laffan - Health-related quality of life issues in patients with non- metastatic neuroendocrine neoplasms persist after treatment Published in 2024 Listed under OT Download [O10] Skotte - Demystifying DIPNECH: Initial Findings from a New Longitudinal Patient Registry Published in 2024 Listed under OT Download [C9] Poster - Halfdanarson - Cabozantinib Versus Placebo for Advanced Neuroendocrine Tumors after Progression on Prior Therapy (CABINET Trial/Alliance A021602) Published in 2024 Listed under Clinical, Poster Download [C9] Halfdanarson - Updated Results of CABINET Trial/Alliance A021602: Cabozantinib Versus Placebo for Advanced Neuroendocrine Tumors (NET) after Progression on Prior Therapy Published in 2024 Listed under Clinical Download [C8] Poster - Mosalem - Temozolomide Induced Hypermutation in Pancreatic Neuroendocrine Tumors: A Case Series Published in 2024 Listed under Clinical, Poster Download [C8] Mosalem - Temozolomide Induced Hypermutation in Pancreatic Neuroendocrine Tumors: A Case Series Published in 2024 Listed under Clinical Download [C7] Schnell - Cabozantinib therapy in patients with previously treated well differentiated grade 3 neuroendocrine tumors (G3 NETs) Published in 2024 Listed under Clinical Download [C7] Poster - Schnell - Cabozantinib therapy in patients with previously treated well differentiated grade 3 neuroendocrine tumors (G3 NETs) Published in 2024 Listed under Clinical, Poster Download [C6] Young - Evaluation of Switching SSAs on GI-NET Progression – Experience at an Academic Medical Center Published in 2024 Listed under Clinical Download [C6] Poster - Young - Evaluation of Switching SSAs on GI - NET Progression: Experience at an Academic Medical Cente Published in 2024 Listed under Clinical, Poster Download [C5] Chauhan - Once-daily Oral Paltusotine in the Treatment of Patients With Carcinoid Syndrome: Results From a Phase 2, Randomized, Parallel-Group Study Published in 2024 Listed under Clinical Download [C4] Poster - Koch - Comparison of Survival Outcomes and Hypoglycemic Control in Patients Receiving Systemic Therapy for Malignant Insulinoma Published in 2024 Listed under Clinical, Poster Download [C4] Koch - Comparison of survival outcomes and hypoglycemic control in patients receiving systemic therapy for malignant insulinoma Published in 2024 Listed under Clinical Download [C49] Su - National trends in surgical management of T1N0 well- differentiated pancreatic neuroendocrine tumors (PNET) and age-specific survival Published in 2024 Listed under Clinical Download [C49] Poster - Su - National Trends in Surgical Management of T1N0 Well - Differentiated Pancreatic Neuroendocrine Tumors (PNET) and Age Specific Survival Published in 2024 Listed under Clinical, Poster Download [C48] Poster - Collier - Impact of Hospital Type and Location on Survival Outcomes for Patients with Well - Differentiated Pancreatic Neuroendocrine Tumors Published in 2024 Listed under Clinical, Poster Download [C48] Collier - Impact of Hospital Type and Location on Survival Outcomes for Patients with Well-Differentiated G1/G2 Pancreatic Neuroendocrine Tumors Published in 2024 Listed under Clinical Download [C47] Slaby - Response After Neoadjuvant Therapy for Pancreatic Neuroendocrine Tumors Published in 2024 Listed under Clinical Download [C47] Poster - Slaby - Response After Neoadjuvant Therapy for Pancreatic Neuroendocrine Tumors Published in 2024 Listed under Clinical, Poster Download [C46] Dumitra - Clinical utility of preoperative DOTATATE-PET in small bowel neuroendocrine tumors Published in 2024 Listed under Clinical Download [C45] Poster - Nkie - Interaction Between Race and Insurance Coverage for Gastroenteropancreatic Neuroendocrine Tumor Outcomes Published in 2024 Listed under Clinical, Poster Download [C45] Nkie - Interaction Between Race and Insurance Coverage for Gastroenteropancreatic Neuroendocrine Tumor Outcomes Published in 2024 Listed under Clinical Download [C44] Shi - Incidence and prognostic analysis of neuroendocrine differentiation in CRC, GC, ESCC and BTC cohorts Published in 2024 Listed under Clinical Download [C43] Wornow - To Treat or Not to Treat: Resection of Primary Pancreatic Neuroendocrine Tumors in the Metastatic Setting Published in 2024 Listed under Clinical Download [C43] Poster - Wornow - To Treat or Not to Treat: Resection of Primary Pancreatic Neuroendocrine Tumors in the Metastatic Setting Published in 2024 Listed under Clinical, Poster Download [C42] Poster - Evans - Loss of MGMT Protein Expression by Immunohistochemistry is Associated with Response to Capecitabine/Temozolomide in Neuroendocrine Neoplasms (NENs) Published in 2024 Listed under Clinical, Poster Download [C42] Evans - Loss of MGMT protein expression by immunohistochemistry is associated with response to capecitabine/temozolomide in neuroendocrine neoplasms (NENs) Published in 2024 Listed under Clinical Download [C41] Yogo - Long-term Survival Outcomes After Minimally Invasive Surgery for Ileal Neuroendocrine Tumors Published in 2024 Listed under Clinical Download [C41] Poster - Yogo - Long-term Survival Outcomes After Minimally Invasive Surgery for Ileal Neuroendocrine Tumors Published in 2024 Listed under Clinical, Poster Download [C40] Winters - Implementation of dosimetry in clinical Lu177-DOTATATE therapy Published in 2024 Listed under Clinical Download [C3] Uberroth - Prolonged Response to Dabrafenib/Trametinib in Metastatic Well-Differentiated Grade 3 Pancreatic Neuroendocrine Tumor (NET G3) with BRAF V600E Mutation Published in 2024 Listed under Clinical Download [C39] Winters - Dosimetry-guided 131I-mIBG Therapy in a Hemodialysis- Dependent Paraganglioma Patient Published in 2024 Listed under Clinical Download [C38] Schnell - Radioactivity in drained body cavity fluid following peptide receptor radionuclide therapy with 177Lu DOTATATE in patients with advanced neuroendocrine tumors Published in 2024 Listed under Clinical Download [C38] Poster - Schnell - Radioactivity in drained body cavity fluid following peptide receptor radionuclide therapy with 177Lu DOTATATE in patients with advanced neuroendocrine tumors Published in 2024 Listed under Clinical, Poster Download [C37] Wahl - Preliminary safety and efficacy data of [212Pb]VMT- α -NET in somatostatin receptor 2 (SSTR2) expressing neuroendocrine tumors (NETs) Published in 2024 Listed under Clinical Download [C36] Patel - Safety and Efficacy of Peptide Receptor Radionuclide Therapy in Thymic Neuroendocrine Neoplasms: A Single-Institutional Case Series Published in 2024 Listed under Clinical Download [C35] Poster - Jacques - Small bowel obstruction incidence in Lu177 PRRT patients had no impact on overall survival Published in 2024 Listed under Clinical, Poster Download [C35] Jacques - Small bowel obstruction incidence in Lu177 PRRT patients had no impact on overall survival Published in 2024 Listed under Clinical Download [C34] Tuchayi - Peptide Receptor Radionuclide Therapy with 177 Lu- DOTATATE: A Single Center Experience Published in 2024 Listed under Clinical Download [C34] Poster - Tuchayi - Peptide Receptor Radionuclide Therapy with 177 Lu - DOTATATE: A Single Center Experience Published in 2024 Listed under Clinical, Poster Download [C33] Cass - Corticosteroid prophylaxis did not decrease tumor flare reaction in high-risk neuroendocrine tumors patients treated with 177Lu-DOTATATE Published in 2024 Listed under Clinical Download [C32] Bilgin - Outcomes of Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE in Patients with Malignant Pheochromocytoma (PCC) and Paraganglioma (PGL): A Single Institution Retrospective Study Published in 2024 Listed under Clinical Download [C31] Singh - First-Line Efficacy of [177Lu]Lu-DOTA-TATE in Gastroenteropancreatic Neuroendocrine Tumors by Tumor Grade and Primary Origin: Phase 3 NETTER-2 Subgroup Analysis Published in 2024 Listed under Clinical Download [C30] Maratta - Somatostatin receptor expression of gastroenteropancreatic neuroendocrine tumors: A comprehensive analysis of expression in the era of somatostatin receptor PET imaging Published in 2024 Listed under Clinical Download [C2] Sun - Preliminary clinical activity of surufatinib combined with octreotide LAR in patients with G1/2 gastroenteropancreatic neuroendocrine tumor (GEP-NET) Published in 2024 Listed under Clinical Download [C29] Poster - D'Souza - Integrating Yttrium - 90 Radioembolization with Capecitabine - Temozolomide for Grade 3 Liver - Dominant Metastatic Neuroendocrine Tumors: Initial Outcomes Published in 2024 Listed under Clinical, Poster Download [C29] D'Souza - Initial Outcomes of Integrating Yttrium-90 Radioembolization with Capecitabine-Temozolomide for Grade 3 Liver-Dominant Metastatic Neuroendocrine Tumors Published in 2024 Listed under Clinical Download [C28] Zhou - Liver-directed therapy for metastatic neuroendocrine carcinoma and grade 3 well-differentiated neuroendocrine tumors Published in 2024 Listed under Clinical Download [C28] Poster - Zhou - Liver - directed therapy for metastatic neuroendocrine carcinoma and grade 3 well - differentiated neuroendocrine tumors Published in 2024 Listed under Clinical, Poster Download [C27] Poster - Fidelman - A Pilot Study of Pembrolizumab and Peptide Receptor Radionuclide Therapy for Patients with Metastatic Grade 2/3 Well - Differentiated Neuroendocrine Tumors Published in 2024 Listed under Clinical, Poster Download Select the number of documents per page 5 10 15 20 25 30 50 100 12»
